Dicot Pharma AB (STO:DICOT)
Sweden · Delayed Price · Currency is SEK 0.2268
-0.0002 (-0.09%)
At close: Sep 24, 2026
Dicot Pharma AB Market Cap
Dicot Pharma AB has a market cap or net worth of 786.7 million as of September 24, 2026. Its market cap has decreased by -53.56% in one year.
Market Cap
786.70M
Enterprise Value
538.30M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.23
ChartMarket Cap Chart
Since June 20, 2018, Dicot Pharma AB's market cap has increased from 63.22M to 786.70M, an increase of 1,144.44%. That is a compound annual growth rate of 35.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 786.70M | 27.53% |
| Dec 30, 2025 | 616.87M | 43.01% |
| Dec 30, 2024 | 431.35M | 65.92% |
| Dec 29, 2023 | 259.98M | 464.37% |
| Dec 30, 2022 | 46.07M | -35.49% |
| Dec 30, 2021 | 71.41M | 56.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioGaia AB | 11.15B |
| Cereno Scientific AB | 1.32B |
| Nanexa AB | 1.05B |
| EQL Pharma AB | 689.52M |
| Cinclus Pharma Holding AB | 546.35M |
| Moberg Pharma AB | 514.27M |
| Orexo AB | 436.52M |
| Enzymatica AB | 412.65M |